The global pharmaceutical packaging market size was valued at USD 110.55 billion in 2024. It is projected to be worth USD 116.58 billion in 2025 and reach USD 177.12 billion by 2032, exhibiting a CAGR of 6.16% during the forecast period. North America dominated the pharmaceutical packaging market with a market share of 30% in 2024.
The growing adoption of novel and generic drugs in developing countries will have an excellent impact on the global market, states Fortune Business Insights, in a report, titled “Pharmaceutical Packaging Market Size, Share & Industry Analysis, By Material (Plastics, Glass, Metal, Paper & Paperboard,), By Product (Plastic Bottles, Caps & Closures, Pre-Fillable Inhalers, Pre-Fillable Syringes, Vials & Ampoules, Blister Packs, Bags & Pouches, Jars & Canisters, Cartridges,), By Packaging Type (Primary, Secondary, and Tertiary), By Drug Delivery Mode), and Regional Forecast, 2025-2032.”
Request a FREE Sample Copy: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pharmaceutical-packaging-market-102860
The Report Lists the Key Companies in the Pharmaceutical Packaging Market:
Gerresheimer AG (Germany)
Origin Pharma Packaging (UK)
Nelipak Healthcare (Alberta)
Pharma Packaging Solutions (TN)
SCHOTT AG (Germany)
Becton Dickinson & Company (US)
West Pharmaceutical Services, Inc. (US)
WestRock (US)
AptarGroup, Inc. (US)
Berry Global, Inc (US)
NIPRO (Japan)
Carcano Antonio S.p.A. (Italy)
SABIC (Saudi Arabia)
Lonza Group AG (Switzerland)
Market Driver:
Booming Pharmaceutical Industry to Boost Market
The flourishing pharmaceutical industry in developing nations such as China, India, and Brazil and developed economies such as the US, UK, and Germany will spur lucrative opportunities for the market during the forecast period. The increasing technological advancements and healthcare spending will contribute positively to the market growth. The growing healthcare awareness along with mandatory government regulations to curb the spread of infectious diseases will have a tremendous effect on the market. Moreover, the inflated demand for biological products and emerging treatments like cell and gene therapies will further enable the speedy expansion of the market.
Pharmaceutical Industry to Remain Unaffected During COVID-19 Pandemic
The coronavirus has disrupted various industries, resulting in the shortage of laborers & raw materials, distraught production processes, as well as transportation and logistics. However, the pharmaceutical industry remained unaffected owing to the government's support for the supply of essential drugs and goods. Pharmaceutical industries remained operational throughout the pandemic to manufacture healthcare products. The government backing for COVID kits and masks further encouraged packaging companies to accelerate their business amid the pandemic. The ongoing automated operations have increased sales in recent years, in turn, promoting the growth of the market.
Regional Analysis:
Heavy Demand for Packaging Products to Aid Expansion in North America
The market in North America is expected to hold the largest share during the forecast period owing to the rapidly flourishing pharmaceutical industry. The increasing demand for packaging products will further enable speedy expansion in the region. The growing healthcare spending and rising prevalence of diseases will further spur demand in the region. The increasing utilization of pharmaceutical products such as plastic bottles & containers, vials & ampoules, and pre-fillable syringes will bolster the healthy growth of the market in North America. Asia Pacific is expected to hold a significant share in the global market owing to the growing pharmaceutical industry in countries such as China, Japan, and India. The rising investments by pharmaceutical manufacturing companies will contribute positively to the market growth.
The report on the pharmaceutical packaging market encompasses:
Grander analysis of the market
Important insights into the competitive landscape
Factors restricting market growth
Recent trends and development
Prime factors enabling growth
Information Source: https://www.fortunebusinessinsights.com/pharmaceutical-packaging-market-102860
Key Development:
January 2024- SGD Pharma launched the extension of its Clareo range to include 10ml and its Sterinity range of ready-to-use vials in sizes 10ml and 20m. The Clareo range of molded glass vials is available in sizes from 10ml to 200ml. These vials are designed to meet American market specifications and have a GPI 20 neck finish.
May 2022- Bormioli Pharma, a manufacturer of glass and plastic primary packaging for pharmaceutical use, announced the launch of EcoPositive, a label for its sustainable packaging solutions. It includes recycled glass and plastics, bio-based, biodegradable, or compostable plastic solutions, and advanced polymer products.